Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon alfa-2b eye drops vs intraoperative mitomycin C for prevention of pterygium recurrence
IRCT20160919029871N5Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Dec 2021
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of interferon alfa-2b in pterygium (2 arms), sponsored by Guilan University of Medical Sciences. Primary endpoint: Pterygium recurrence rate. Started Dec 2021; status: completed.
02
Drugs
interferon alfa-2b
03
Conditions
pterygium
Beyond the preview
Go deeper on IRCT20160919029871N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160919029871N5.